type here...

CATEGORIES

Healthcare

LATEST

1...212223...75Page 22 of 75

TRENDING

EDITORS CHOICE

FREOPP Study: How New York’s Single Payer Health Care Bill Affects the Working Poor

Medika Life -
The flawed design of the New York Health Act would be felt most acutely by low-income New Yorkers, a new FREOPP study finds. This Single-Payer Health

Nonsensical Processes Prevent Patient Access to New and Safe Treatments

Dr Jeff Livingston -
Health technological innovations only have value if doctors and patients have access to them. Insurance companies label new products as investigational to justify the denial of care.

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Tariffs Can Upset the World of Healthcare and Medications

Pat Farrell PhD -
Medications subject to tariff could mean a return to readily available cultural, homeopathic medications.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories